Infectious Disease
-
Data support use of nirsevimab prophylaxis to reduce RSV hospitalization risk for infants
Retrospective data show significantly fewer infants were hospitalized for RSV after nirsevimab became available. Among the RSV hospitalizations that occurred during that time period, 75% were in infants who had not received nirsevimab.
-
While still elevated, early 2026 data show US influenza A cases stabilizing or decreasing
Infectious disease expert Frederick G. Hayden, MD, said timely use of antivirals for prophylaxis and treatment can minimize the impact of this flu season, which has seen a significant mismatch between vaccines and the circulating strain.
-
De-escalating antibiotics proves safe for patients with community-onset sepsis
Ashwin B. Gupta, MD, addresses lingering clinician hesitancy surrounding the de-escalation of antibiotics for adults hospitalized for community-onset sepsis.
-
AI-enabled approaches poised to transform diagnosis, management of lung diseases
Experts explore how AI-based tools can be used to bridge diagnostic challenges and address unmet needs in chronic respiratory disease care.
-
Study shows glucocorticoids cut mortality in community acquired pneumonia in low-income settings
Anthony O. Etyang, MBChB, MMed, MSc, PhD, said recent data bolster the evidence that steroids may be useful for severe pneumonia in high-income settings as well.
-
Trials suggest RSV vaccine reduces hospitalization for cardiorespiratory conditions in older adults
Data from studies in the United States and Denmark add to the growing evidence that respiratory syncytial virus (RSV) vaccination is effective in older adults.
-
Oseltamivir found to lower risk of flu-linked neuropsychiatric events in children
This study is the largest and most comprehensive US investigation of the drug and severe neuropsychiatric events, said author James Antoon, MD, PhD, MPH.
-
Data suggest pneumococcal vaccination is underused
Respiratory medicine expert Christina Thornton, MD, PhD, said recent real-world data demonstrate high rates of community-acquired pneumonia driven by serotypes targeted by vaccines.
-
Case discussions to address complexities of mediastinal lymphadenopathy diagnosis
Sebastian Kurz, MD, PhD, FCCP, will chair a Wednesday afternoon panel session that will guide attendees through imaging findings, differential diagnoses, and clinical decision-making in mediastinal lymphadenopathy.
-
Experts discuss advances in understanding, management of chronic cough
Sumera Ahmad, MBBS, discussed pharmacological innovations for chronic cough, including P2X3 antagonists, opiates, and neuromodulators.
